Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
出版年份 2013 全文链接
标题
Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
作者
关键词
Ovarian cancer, Chemotherapy resistance, Biomarkers, Gene expression, Microarray
出版物
BMC CANCER
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-11-16
DOI
10.1186/1471-2407-13-549
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family
- (2012) Stephen C. Artim et al. BIOCHEMICAL JOURNAL
- Insulin-like Growth Factor-I Concentration and Risk of Prostate Cancer: Results from the European Prospective Investigation into Cancer and Nutrition
- (2012) A. J. Price et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells
- (2012) Man-Tat Lau et al. CANCER LETTERS
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- Validated gene targets associated with curatively treated advanced serous ovarian carcinoma
- (2012) Joyce N. Barlin et al. GYNECOLOGIC ONCOLOGY
- Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell
- (2012) Neetu Kalra et al. INTERNATIONAL JOURNAL OF CANCER
- SCOREM: statistical consolidation of redundant expression measures
- (2012) Stephanie Schneider et al. NUCLEIC ACIDS RESEARCH
- Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
- (2012) Cécile Pierre-Eugene et al. PLoS One
- FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- An integrative approach to identifying cancer chemoresistance-associated pathways
- (2011) Shih-Yi Chao et al. BMC Medical Genomics
- Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
- (2011) Sungshim Lani Park et al. CANCER CAUSES & CONTROL
- Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer
- (2011) Mari-Anne Rowlands et al. CANCER CAUSES & CONTROL
- Visceral obesity and inflammation markers in relation to serum prostate volume biomarkers among apparently healthy men
- (2011) Majed S. Alokail et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
- (2011) Erin R. King et al. GYNECOLOGIC ONCOLOGY
- Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples
- (2011) Tibor Fekete et al. INTERNATIONAL JOURNAL OF CANCER
- Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma
- (2011) Ying Gao et al. INTERNATIONAL JOURNAL OF CANCER
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines
- (2011) H. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
- (2011) Clair L. Alvino et al. PLoS One
- Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture
- (2010) Jozien Helleman et al. GYNECOLOGIC ONCOLOGY
- Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
- (2010) E. Buck et al. MOLECULAR CANCER THERAPEUTICS
- Targeted Therapies in Epithelial Ovarian Cancer
- (2010) Nicanor I. Barrena Medel et al. Journal of Oncology
- Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
- (2009) Lovisa Österberg et al. BMC CANCER
- Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
- (2009) N. Eckstein et al. CANCER RESEARCH
- -Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model
- (2009) E. Ashihara et al. CLINICAL CANCER RESEARCH
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
- (2009) D. Etemadmoghadam et al. CLINICAL CANCER RESEARCH
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
- (2009) Woong Ju et al. ONCOLOGY RESEARCH
- Treatment for Recurrent Ovarian Cancer—At First Relapse
- (2009) Kimio Ushijima Journal of Oncology
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- arrayQualityMetrics—a bioconductor package for quality assessment of microarray data
- (2008) Audrey Kauffmann et al. BIOINFORMATICS
- Wnt Signaling in the Niche Enforces Hematopoietic Stem Cell Quiescence and Is Necessary to Preserve Self-Renewal In Vivo
- (2008) Heather E. Fleming et al. Cell Stem Cell
- Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women
- (2008) Ibrahim Serdar Serin et al. GYNECOLOGICAL ENDOCRINOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started